Capilitan, Jelly Be .
HRN: 03-02-87 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
CO-AMOXICLAV 625MG (TAB)
06/02/2026
06/09/2026
PO
625MG
BID
NKA
Checking Initial Appropriateness